Nausea, vomiting, diarrhoea, constipation, and abdominal pain affect a significant proportion of patients, particularly during dose escalation
Rather than semaglutide, for instance, they might use semaglutide sodium, which is a version of the drug that has a sodium salt attached
In summary, observational studies have not found an increased risk of PDAC during short term follow-up
The second class is inhibitors of the GLP-1 degrading enzyme, dipeptidyl pepitidase IV (Sitagliptin and related drugs) which can be given orally and increase the plasma level of GLP-1 and other peptides degraded by DPP-4
The storage instructions provided with your medication will be your go-to resource